Diagnostic value and research progress of neuroimaging in Parkinson's disease and Parkinson-plus syndromes

by Hai-lun CUI, Ru-jing REN, Gang WANG
Published 2018-04-01

A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9

by Lun Cui, Antoine Vigouroux, François Rousset, Hugo Varet, Varun Khanna, David Bikard
Published 2018-05-01

Genome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors.

by François Rousset, Lun Cui, Elise Siouve, Christophe Becavin, Florence Depardieu, David Bikard
Published 2018-11-01

Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria

by Aude Bernheim, Alicia Calvo-Villamañán, Clovis Basier, Lun Cui, Eduardo P. C. Rocha, Marie Touchon, David Bikard
Published 2017-12-01

Progress of translational research on the pathogenesis, diagnosis and treatment of Parkinson's disease

by Gang WANG, Hai-lun CUI, Jun LIU, Jian-qing DING, Qin XIAO, Jian-fang MA, Sheng-di CHEN
Published 2018-01-01

Current approaches for the management of Parkinson’s disease in Chinese hospitals: a cross-sectional survey

by Gang Wang, Hai-Lun Cui, Jun Liu, Qin Xiao, Ying Wang, Jian-Fang Ma, Hai-Yan Zhou, Jing Pan, Yu-Yan Tan, Sheng-Di Chen, on behalf of the Chinese Movement Disorders Society
Published 2018-08-01

Lipoprotein DolP supports proper folding of BamA in the bacterial outer membrane promoting fitness upon envelope stress

by David Ranava, Yiying Yang, Luis Orenday-Tapia, François Rousset, Catherine Turlan, Violette Morales, Lun Cui, Cyril Moulin, Carine Froment, Gladys Munoz, Jérôme Rech, Julien Marcoux, Anne Caumont-Sarcos, Cécile Albenne, David Bikard, Raffaele Ieva
Published 2021-04-01